← All trials
NCT07223125
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 10, 2025
- Primary completion
- Dec 15, 2026
- Completion date
- Aug 15, 2028
- First posted
- Oct 31, 2025
- Last posted
- Nov 7, 2025
- Enrollment
- 360
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.